Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan

Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease associated with increased prevalence of type 2 diabetes mellitus (T2DM). Here, we investigated the effect of the combination of cyclooxygenase (COX)-2 inhibitors and metformin on the rate of admission in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chieh-Hua, Chung, Chi-Hsiang, Lee, Chien-Hsing, Su, Sheng-Chiang, Liu, Jhih-Syuan, Lin, Fu-Huang, Tsao, Chang-Huei, Hsieh, Po-Shiuan, Hung, Yi-Jen, Hsieh, Chang-Hsun, Chien, Wu-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799465/
https://www.ncbi.nlm.nih.gov/pubmed/31593087
http://dx.doi.org/10.1097/MD.0000000000017371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799465/
https://www.ncbi.nlm.nih.gov/pubmed/31593087
http://dx.doi.org/10.1097/MD.0000000000017371

Ejemplares similares